Skip to:


Feb 19 | Life Science Sweden writes about Mabtech

Swedish biotech newspaper Life Science Sweden has picked up the news about Niklas Ahlborg becoming CEO of Mabtech. Here is a link to the article (in Swedish): more

Feb 15 | Mabtech appoints Niklas Ahlborg as new CEO

Today, February 15 2018, Mabtech announces that Niklas Ahlborg, PhD, has been appointed new Chief Executive Officer, replacing Staffan Paulie who will continue on the Board of Directors.

Hi Niklas! CEO of Mabtech – how did that happen?
I have been the head of R&D for 17 years and understand that part of the company well. When I was asked about this new opportunity it felt like an exciting challenge and a chance to learn new things. more

"Overall, I would say your Mouse apoE ELISA kit is excellent."
S. Malin
Karolinska Institutet
"Our research group uses Mabtech products for a variety of applications, especially investigating immunological responses in wildlife. We have been able to develop new assays for detecting diseases and feel that the quality of the products contributes to our research progress. The support from the Mabtech staff has been especially positive and we look forward to future collaborations."
Michele Miller
Division of Molecular Biology & Human Genetics
Faculty of Medicine and Health Sciences
Stellenbosch University
South Africa
"I really like your company and people working there, always open for discussion and online."
Olga Ticha, PhD